Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines

Annals of Clinical and Laboratory Science

Volumn 30, Issue 4, 2000, Pages 395-405

  Parker, L P ^a   Wolf, J K ^a   Price, J E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Breast cancer; Chemotherapy; Gene therapy; Radiation; Transfection

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P21; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL PROTECTION; GAMMA IRRADIATION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANNEXIN V; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYCLINS; CYTOMEGALOVIRUS; DRUG THERAPY; FEMALE; FLOW CYTOMETRY; GENE THERAPY; HUMAN; PROMOTER REGIONS (GENETICS); PROTEIN P53; RADIOTHERAPY; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033789630     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor
2. The p53 tumor suppressor gene in breast cancer
3. Oncogenes and tumor suppressor genes
4. In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation
5. p21 (WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumors
6. Cancer cell cycles
7. DNA damage, oncogenesis and the p53 tumor-suppressor gene
8. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles
9. Expression of the cyclin-dependent kinase inhibitors p16(INK4), p15(INK4B), and p21(WAF1/CIP1) in human breast cancer
10. Perturbation of cell cycle regulators in human cancer
11. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug
12. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells
13. Adenovirally transferred p16(INK4/CDKN2) and p53 genes cooperate to induce apoptotic tumor cell death
14. Radiation-induced cell cycle arrest compromised by p21 deficiency
15. UVB radiation induces p21(Cip1/WAF1) and mediates G1 and S phase checkpoints
16. Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction
17. Role of p21(WAF1/Cip1/Sdi1) in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells
18. Repair defect in p21(WAF1/CIP1-/-) human cancer cells
19. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus
20. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
21. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation
22. Ionizing radiation greatly improves gene transfer efficiency in mammalian cells
23. Breast tumor cell lines from pleural effusions
24. Long-term human breast cancer cell lines of metastatic origin: Preliminary characterization
25. Metastasis from human breast cancer cell lines
26. Adenoviral mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation
27. p53 Mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy
28. Morphological and biochemical characterization and analysis of apoptosis
29. In vivo detection and imaging of phosphatidyl-serine expression during programmed cell death
30. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
31. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2
32. Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer
33. Retro-virus mediated wild-type p53 gene transfer to tumors of patients with lung cancer
34. p16(INK4A) adenovirus-mediated gene therapy for human head and neck squamous cell cancer
35. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
36. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
37. A model for p53-induced apoptosis
38. Identification of human p53 mutations with differential effects on the Bax and p21 promoters using functional assays in yeast
39. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells
40. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
41. Induction of waf1/cip1 by a p53-independent pathway
42. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells
43. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low-dose ionizing radiation in A431 squamous carcinoma cells
44. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy
45. Molecular aspects of cellular responses to radiotherapy
46. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
47. Cell-cycle arrest versus cell death in cancer therapy
48. Evidence that mammalian cells possess homologous recombinational pathways
49. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis
50. Functional expression of human p21 (WAF1/CIP1) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity
51. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-Bis (2-chloroethyl)-1-nitrosourea and cisplatin
52. Tumor suppression by p21(WAF1)